News and Updates
CanPath Webinar: COVID-19 Antibody Study Results
Mar 23, 2022 // Study Updates
Beginning December 2020, select CanPath participants were invited to complete a follow-up COVID-19 questionnaire and submit dried blood spot samples. The questionnaire included details around vaccination, previous COVID-19 infection, underlying medical conditions, and medications taken. Dried blood spot samples were tested for antibodies to SARS-CoV-2 (anti-spike IgG, anti-receptor binding domain of spike (RBD) IgG, and anti-nucleocapsid (N) IgG). Collection
Join our very first Participant Town Hall!
Feb 15, 2022 // Study Updates
OHS participants – Join our very first participant webinar happening February 24th! The OHS is one of seven regional studies that make up Canada’s largest health research platform, the Canadian Partnership for Tomorrow’s Health (CanPath). Join the Town Hall discussion to learn how your questionnaire data and blood samples are making a difference. Register today
CanPath: Canada’s Population Platform for Personalized Medicine
Feb 15, 2022 // Study Updates
The emerging field of personalized medicine, or precision medicine, offers huge potential to help doctors tailor medical treatments to the individual, based on their medical history and personal circumstances. Read how CanPath (and the OHS, as its largest contributor) is helping researchers explore how biology, behaviours, and environmental exposures influence the development of chronic diseases
Data from 10,000 OHS participants studied for vaccine effectiveness
Feb 8, 2022 // Study Updates
Ontario Health Study investigators merited a $500,000 CIHR operating grant to relate COVID-19 antibody levels to vaccine effectiveness by looking at COVID-19 infection levels, hospitalization rates and deaths in vaccinated OHS participants. They will also assess how immune response to vaccination varies by: Type of vaccine (AstraZeneca, Pfizer or Moderna) including mixed doses Number of
